A Phase 1 Study of Mosliciguat in Healthy, Adult Males

Completed · Phase 1

Conditions studied: Healthy Volunteer

In brief

This is a single-center, Phase 1, open-label, 3-period, fixed-sequence study to investigate the bioavailability, absorption, metabolism, excretion and the safety of mosliciguat administered to healthy male adults.

Key facts

Study ID

NCT07185321

Run by

Pulmovant, Inc.

People needed

8

Starts

2025-06-10

Expected to finish

2025-07-13

Last updated by the study team

2026-06-16

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Participants willing and able to provide informed consent.
• Considered to be in good health by the Investigator, as determined by medical history, physical examination, vital sign measurements, 12 lead electrocardiogram (ECG), and laboratory test results.

You may not qualify if…

• History or presence of any condition (e.g., chronic diarrhea, urinary incontinence), or prior surgery (e.g., gastric bypass) that, in the opinion of the Investigator, poses a significant risk to participant safety and/or achievement of study objectives
• History or presence of COPD, moderate or persistent asthma, other chronic lung disease, or chronic respiratory condition within the last 5 years
• Acute or recent respiratory infection symptoms not resolved at least 3 days prior to Period 1 check-in.

Where it is running

• Pharmaron — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.